As pharmaceutical companies become increasingly focused on retaining key sales people, they continually consider ways to leverage variable compensation as a strategic tool for maximizing the return on their investment in top talent.
Partha S. Anbil
Advertisement
Articles by Partha S. Anbil
The discrepancies between trial and real-life patient conditions are such that Real-World Evidence (RWE) can be utilized to supplement this process.
Advertisement
Latest Updated Articles
Is There Evidence in Real-World Evidence?Published: March 15th 2019 | Updated:
Pharma's Incentive Compensation Plan LandscapePublished: April 1st 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Alkermes plc Acquiring Avadel Pharmaceuticals in $2.1 Billion Definitive Agreement
2
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
3
Novo Nordisk Stock Reacts to Recent Board Changes
4
What Impact will DTC Programs Have on Prescription Drug Prices?
5
